Entera Bio Ltd. (ENTX)
NASDAQ·Healthcare·Biotechnology
$1.13
-2.17%
Mkt Cap $60.99M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | -$0.11 | -$0.06 | +45.45% | — | — |
| Q2 2025 May 9, 2025 | — | $42.00K | — | -$0.07 | -$0.06 | +14.29% | — | — |
| Q1 2025 Mar 28, 2025 | $40.00K | $82.00K | +105.00% | -$0.08 | -$0.06 | +25.00% | — | — |
| Q4 2024 Nov 8, 2024 | $40.00K | $42.00K | +5.00% | -$0.05 | -$0.08 | -60.00% | — | — |
| Q3 2024 Aug 9, 2024 | — | $57.00K | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q1 2024 Mar 8, 2024 | — | $4.48M | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q3 2023 Aug 11, 2023 | — | $14.00K | — | -$0.07 | -$0.08 | -14.29% | — | — |
| Q2 2023 May 5, 2023 | $100.00K | $13.00K | -87.00% | -$0.12 | -$0.08 | +33.33% | — | — |
| Q1 2023 Mar 27, 2023 | $50.00K | $14.00K | -72.00% | -$0.11 | -$0.11 | -1.26% | — | — |
| Q4 2022 Nov 10, 2022 | $70.00K | $8.00K | -88.57% | -$0.16 | -$0.11 | +31.25% | — | — |
| Q3 2022 Aug 11, 2022 | $100.00K | $44.00K | -56.00% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q2 2022 May 12, 2022 | $178.50K | $68.00K | -61.90% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q1 2022 Mar 8, 2022 | $127.00K | $165.00K | +29.92% | -$0.11 | $0.21 | +290.91% | — | — |
| Q4 2021 Nov 10, 2021 | $189.00K | $140.00K | -25.93% | -$0.10 | -$0.05 | +50.00% | — | — |
| Q3 2021 Aug 16, 2021 | $91.05K | $109.00K | +19.72% | -$0.10 | -$0.19 | -90.00% | — | — |
| Q2 2021 May 20, 2021 | $223.72K | $157.00K | -29.82% | -$0.12 | -$0.43 | -258.33% | — | — |